Abattis Bioceuticals Corp.

ATTBF

CA00258G1037

Healthcare Facilities & Services

Market Closed - OTC Markets Other stock markets 01:48:09 2024-05-16 pm EDT			5-day change	1st Jan Change
0.000001 ^USD	0.00%		-99.00%	0.00%

2020	Abattis Bioceuticals Corp. Reports Earnings Results for the Full Year Ended September 30, 2019	CI
2019	Abattis Bioceuticals Corp. Announces Board Changes	CI

Abattis Bioceuticals Corp. Announces Resignation of Dr. Shuang Xie as Chief Technology Officer and Director

January 14, 2018

Abattis Bioceuticals Corp. announced the resignation of Dr. Shuang Xie as chief technology officer and a director of the Company.

Latest news about Abattis Bioceuticals Corp.

Abattis Bioceuticals Corp. Reports Earnings Results for the Full Year Ended September 30, 2019	20-04-29	CI
Abattis Bioceuticals Corp. Announces Board Changes	19-11-08	CI
Abattis Bioceuticals Corp. (OTCPK:ATTB.F) cancelled the acquisition of NutriVida Corp.	19-11-07	CI
Abattis Bioceuticals Corp. Reports Earnings Results for the Third Quarter Ended June 30, 2019	19-08-27	CI
Abattis Bioceuticals Corp.'s Equity Buyback announced on August 7, 2018, has expired.	19-08-14	CI
Abattis Bioceuticals Corp. Reports Earnings Results for the Full Year Ended September 30, 2018	19-08-07	CI
Abattis Bioceuticals Corp. (OTCPK:ATTB.F) cancelled the acquisition of Winston Resources Inc..	19-06-27	CI
Abattis Bioceuticals Corp. (OTCPK:ATTB.F) completed the acquisition of Pro Natura BV from The Catalyst Capital Group Inc.	19-05-20	CI
Abattis Bioceuticals Corp. Announces Management Changes	19-04-02	CI
Abattis Bioceuticals Corp. (OTCPK:ATTB.F) agreed to acquire Pro Natura BV from The Catalyst Capital Group Inc. for €15.7 million.	19-04-01	CI
Abattis Bioceuticals Corp. Announces Resignations in Board	19-03-11	CI
British Columbia Securities Commission Removes Temporary Order on Abattis Bioceuticals Corp	19-01-17	CI
Abattis Bioceuticals Corp Announces Launch of Its New Website and Provide an Operational Update	18-12-21	CI
Abattis Bioceuticals Corp. (OTCPK:ATTB.F) signed a letter of intent to acquire NutriVida Corp. for CAD 15 million.	18-12-06	CI
Abattis Bioceuticals Corp Signs a Distribution Agreement with Shefield &Sons Tobacconists Inc. to Sell the Abattis Vaporizer Line in all Shefield &Sons Stores Across Canada	18-11-27	CI
Abattis Bioceuticals Corp. (OTCPK:ATTB.F) acquired Select Strains Inc. for $3.5 million.	18-11-22	CI
Abattis Bioceuticals Corp. Announces Executive Changes	18-11-21	CI
Abattis Intends To Seek Acquisitions	18-11-21	CI
Abattis Bioceuticals Corp. Announces Board Changes	18-10-18	CI
Abattis Bioceuticals Corp. Provides Update on Vaporizer Product Line	18-10-11	CI
Abattis Bioceuticals Provides Phase 1 Update on Research and Development for Nanoemulsification and Liposomal Platforms of Cannabinoid-Rich Hemp Oil	18-10-04	CI
Abattis Bioceuticals Corp. Announces the Pending Release of “Comfort”, A Nutraceutical Designed to Target Chronic Pain and Inflammation	18-09-24	CI
Abattis Bioceuticals Corp. Appoints Nicole Breitinger as Corporate Secretary	18-09-11	CI
Abattis Bioceuticals Corp. to Launch New Products Through Vergence Naturals	18-08-28	CI
Emerald Health Therapeutics, Inc. completed the acquisition of 35% stake in Northern Vine Canada Inc. from Abattis Bioceuticals Corp. (OTCPK:ATTB.F).	18-08-13	CI

Chart Abattis Bioceuticals Corp.

Duration

Period

More charts

Abattis Bioceuticals Corp. is a Canada-based specialty biotechnology company. The Company aggregates, incubates, integrates and invests in the natural health product and botanical drug development industry. It operates through the segment of producing, licensing and marketing ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The Company, through its subsidiaries, develops and commercializes natural health (nutraceutical) products, and conducts research and development to create plant-based (botanical) intellectual property and ingredients for the pharmaceutical and bioceutical markets, among others. It offers products and services, such as botanical blends and formulas; cannabidiol ingredients; functional foods and beverages, and analytical services. It is focused on creating botanical formulations, medical marijuana and specialized health products for pain caused by inflammation, and mental ailments.

Sector

Healthcare Facilities & Services

More about the company

Sector Medical Farming

	1st Jan change	Capi.
ABATTIS BIOCEUTICALS CORP.	0.00%	476
THE CANNABIST COMPANY HOLDINGS INC.	-37.75%	341M
CRUCIAL INNOVATIONS CORP.	-.--%	339M
AYR WELLNESS INC.	+52.26%	299M
ASCEND WELLNESS HOLDINGS, INC.	+35.05%	279M
ORGANIGRAM HOLDINGS INC.	+57.56%	206M
JUSHI HOLDINGS INC.	+52.17%	138M
INTERCURE LTD.	+140.77%	137M
IANTHUS CAPITAL HOLDINGS, INC.	-28.57%	122M
4FRONT VENTURES CORP.	+34.62%	118M

Medical Farming